Pharmababble - Latest Comments in Exelixis and Bristol-Myers Squibb to Co-Develop a Selective Cdc7 Inhibitorhttp://pharmababble.disqus.com/Stream of consciousness pharmaceuticals business developmentenSat, 17 Oct 2009 05:58:31 -0000Re: Exelixis and Bristol-Myers Squibb to Co-Develop a Selective Cdc7 Inhibitorhttp://www.pharmababble.com/exelixis-and-bristol-myers-squibb-to-co-develop-a-selective-cdc7-inhibitor/#comment-20257201<p>test</p>Self StorageSat, 17 Oct 2009 05:58:31 -0000